About Peptic Ulcer Drugs A peptic ulcer is an open lesion, which develops on the mucosal lining of the stomach and the small intestine due to the caustic effect of the gastric acid and pepsin present in these organs. The general symptoms of a peptic ulcer include abdominal pain, nausea, vomiting, and bloated stomach. The specific symptom of peptic ulcer is the bleeding of the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. It is caused mainly by the Helicobacter pylori bacteria followed by the overuse of over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs) like naproxen, aspirin, and ibuprofen. Technavio’s analysts forecast the global peptic ulcer drugs market to grow at a CAGR of 2.80% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global peptic ulcer drugs market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs. The market is divided into the following... Research Beam Model: Research Beam Product ID: 1697067 3500 USD New
Global peptic ulcer drugs market 2017-2021
 
 

Global peptic ulcer drugs market 2017-2021

  • Category : Healthcare
  • Published On : July   2017
  • Pages : 84
  • Publisher : Technavio
 
 
 
About Peptic Ulcer Drugs
A peptic ulcer is an open lesion, which develops on the mucosal lining of the stomach and the small intestine due to the caustic effect of the gastric acid and pepsin present in these organs. The general symptoms of a peptic ulcer include abdominal pain, nausea, vomiting, and bloated stomach. The specific symptom of peptic ulcer is the bleeding of the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. It is caused mainly by the Helicobacter pylori bacteria followed by the overuse of over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs) like naproxen, aspirin, and ibuprofen.

Technavio’s analysts forecast the global peptic ulcer drugs market to grow at a CAGR of 2.80% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global peptic ulcer drugs market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Peptic Ulcer Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• AstraZeneca,
• Daewoong Pharmaceuticals,
• Eisai,
• Takeda Pharmaceutical
Other prominent vendors
• GlaxoSmithKline
• Pfizer
Market driver
• Economics of treating ulcer
• For a full, detailed list, view our report

Market challenge
• Adverse effect of PPIs
• For a full, detailed list, view our report

Market trend
• Bismuth-based quadruple therapy
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Peptic ulcers: Disease overview
PART 06: Key clinical trials

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by drug class
• PPIs
• Antibiotics
• Others
PART 09: Geographical segmentation
• Peptic ulcer drugs market in Americas
• Peptic ulcer drugs market in EMEA
• Peptic ulcer drugs market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Market challenges
PART 12: Market trends
• Bismuth-based quadruple therapy
• Emergence of monotherapy
• Recurrent H. pylori infections
• Rise in awareness
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key vendor analysis
• AstraZeneca
• Daewoong Pharmaceuticals
• Eisai
• Takeda Pharmaceutical
• Other prominent vendors
PART 15: Appendix
• List of abbreviations

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT